| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |